• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受主动脉瓣手术的阵发性夜间血红蛋白尿患者的依库珠单抗治疗。

Eculizumab therapy in paroxysmal nocturnal haemoglobinuria patient undergoing aortic valve surgery.

作者信息

Kusadokoro Sho, Kimura Naoyuki, Hori Daijiro, Yamaguchi Atsushi

机构信息

Department of Cardiovascular Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan.

出版信息

Interact Cardiovasc Thorac Surg. 2019 Jun 1;28(6):994-995. doi: 10.1093/icvts/ivz020.

DOI:10.1093/icvts/ivz020
PMID:30715380
Abstract

Paroxysmal nocturnal haemoglobinuria is a rare disorder characterized by haemolytic anaemia and pancytopaenia. The use of cardiopulmonary bypass can lead to a haemolytic crisis in patients with paroxysmal nocturnal haemoglobinuria due to activation of complement-mediated haemolysis. We report the successful management of a 69-year-old man undergoing aortic valve replacement with standard heparin-protamine protocol by using eculizumab, a monoclonal antibody of complement factor C5. The surgery was performed without triggering a haemolytic crisis, and the patient was discharged from the hospital without major complications.

摘要

阵发性睡眠性血红蛋白尿症是一种罕见的疾病,其特征为溶血性贫血和全血细胞减少。由于补体介导的溶血激活,体外循环的使用可导致阵发性睡眠性血红蛋白尿症患者发生溶血危象。我们报告了一名69岁男性患者成功接受主动脉瓣置换术的病例,该患者采用标准肝素-鱼精蛋白方案,并使用补体因子C5的单克隆抗体依库珠单抗进行治疗。手术未引发溶血危象,患者出院时无重大并发症。

相似文献

1
Eculizumab therapy in paroxysmal nocturnal haemoglobinuria patient undergoing aortic valve surgery.接受主动脉瓣手术的阵发性夜间血红蛋白尿患者的依库珠单抗治疗。
Interact Cardiovasc Thorac Surg. 2019 Jun 1;28(6):994-995. doi: 10.1093/icvts/ivz020.
2
Cardiopulmonary bypass surgery in a patient with paroxysmal nocturnal haemoglobinuria.阵发性夜间血红蛋白尿患者的体外循环手术
Transfus Med. 2006 Jun;16(3):206-8. doi: 10.1111/j.1365-3148.2006.00668.x.
3
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial.依库珠单抗联合口服因子 B 抑制剂依帕司他治疗阵发性睡眠性血红蛋白尿症伴溶血性贫血患者的开放标签、单臂、2 期概念验证试验
Lancet Haematol. 2021 May;8(5):e344-e354. doi: 10.1016/S2352-3026(21)00028-4. Epub 2021 Mar 23.
4
Aortic valve bypass for aortic stenosis in a patient with paroxysmal nocturnal hemoglobinuria.阵发性睡眠性血红蛋白尿症患者主动脉瓣狭窄行主动脉瓣旁路术。
Ann Thorac Surg. 2010 Jul;90(1):279-81. doi: 10.1016/j.athoracsur.2009.11.047.
5
Paroxysmal nocturnal haemoglobinuria: to prednisone or not to prednisone?--a case report of a patient previously treated with steroids for 15 yrs and significant response on eculizumab.阵发性夜间血红蛋白尿:用还是不用泼尼松?—— 一名曾接受15年类固醇治疗且对依库珠单抗有显著反应的患者的病例报告
Eur J Haematol. 2015 Aug;95(2):177-80. doi: 10.1111/ejh.12480. Epub 2015 Mar 29.
6
Successful use of eculizumab in a pediatric patient treated for paroxysmal nocturnal hemoglobinuria.依库珠单抗成功用于治疗阵发性夜间血红蛋白尿的儿科患者。
J Pediatr Hematol Oncol. 2012 Nov;34(8):e346-8. doi: 10.1097/MPH.0b013e318258079a.
7
Cardiac surgery in a patient with paroxysmal nocturnal hemoglobinuria.
Haematologica. 2002 Aug;87(8):ECR29.
8
Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report.1例接受依库珠单抗治疗的阵发性睡眠性血红蛋白尿患者发生溶血性危机,可能由SARS-CoV-2(新冠病毒病)触发:病例报告
Ann Hematol. 2021 Mar;100(3):841-842. doi: 10.1007/s00277-020-04318-6. Epub 2020 Nov 10.
9
Eculizumab in paroxysmal nocturnal haemoglobinuria.依库珠单抗治疗阵发性睡眠性血红蛋白尿症。
Drugs. 2008;68(10):1341-6. doi: 10.2165/00003495-200868100-00001.
10
[Rare case of a pregnancy in a woman with paroxysmal nocturnal hemoglobinuria. Case report].[阵发性夜间血红蛋白尿症女性患者妊娠的罕见病例。病例报告]
Orv Hetil. 2016 Jun 5;157(23):916-8; quiz 919-20. doi: 10.1556/650.2016.30430.